Calistoga Pharmaceuticals begins first clinical trial of novel oral PI3K delta inhibitor March 13, 2008
Abbott enters agreement with Genentech, Roche and OSI to develop gene test for Tarceva March 12, 2008
Positive interim data for Sunesis' lead product candidate in platinum-resistant ovarian cancer March 12, 2008
Multiple targeting yields enhanced preclinical antitumor effects in head and neck cancer March 12, 2008
BioCancell submits pre-IND application to FDA for phase I clinical trials of BC-819 in cancer March 11, 2008
RSS